Wild Biotech
PrivateLast Round
Series A
Oct 16, 2025
Total Funding Raised
$85.31M
Company Overview
Wild Biotech is a biotechnology company that develops an AI-powered drug-discovery platform utilizing an annotated metagenomic database of wild animal microbiota to create new medicines for inflammatory, immune, and gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wild Biotech Comparables
Compare Wild Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pragma Bio | 82% | |
| Xbiome | 78% | |
| Microbiotica | 76% |
Wild Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2025 | ||||
| Grant | Jun 2, 2025 | ||||
| Grant | Jul 1, 2022 |
Wild Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Braavos Investment Advisers | Series A, Seed |
| Oxford Science Enterprises | Series A, Seed |
| University of Oxford | Series A |
| Advanced Research and Invention Agency | Grant |
| Innovate UK | Grant |
| Ellison Institute of Technology | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Secured $9M from Advanced Research and Invention Agency.
- Jul 1, 2022
$370K grant received from Innovate UK.
Wild Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Wild Biotech's valuation, stock price, and market status.
Is Wild Biotech a public or private company?
Wild Biotech is a private company.
What is the current stock price of Wild Biotech?
Wild Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Wild Biotech worth (valuation)?
Valuation information for Wild Biotech is not publicly available.
Can I buy Wild Biotech stock?
Wild Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Wild Biotech's last funding round?
Wild Biotech's most recent funding round was Series A on October 16, 2025.
Who are the main investors in Wild Biotech?
Key investors in Wild Biotech include Braavos Investment Advisers, Oxford Science Enterprises, Ellison Institute of Technology.
Will Wild Biotech IPO soon?
No public IPO plans have been announced for Wild Biotech.
How can I track Wild Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wild Biotech's secondary market activity and sign up for updates.